Healthy Clinical Trial
Official title:
The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain
This study sets out to investigate the potential effect of auditory disturbances on human movement
Status | Not yet recruiting |
Enrollment | 44 |
Est. completion date | September 30, 2026 |
Est. primary completion date | September 30, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Control group: Inclusion Criteria (Control): - Able to speak, read and understand Danish/English Exclusion Criteria (Control): - Pain from the neck or shoulder area during the past 6 months - Experience of delayed onset muscle soreness (DOMS) during the week leading up to the test session - Former surgery in neck or shoulder - Current or previous chronic or recurrent pain condition that could affect the results - Pregnancy - Drug addiction defined as the use of cannabis, opioids or other drugs - Previous neurologic, musculoskeletal or mental illnesses that could affect the results - Regular use of analgesics - Abnormally disrupted sleep in the last 24 hours preceding the experiment - Lack of ability to cooperate Neck pain group: Inclusion Criteria (Neck Pain): - Traumatic onset of neck pain - Able to speak, read and understand Danish/English - Reduced/painful active range of motion of the head and/or painful reaction to palpation of the neck at the time of inclusion Exclusion Criteria (Neck Pain): - Experience of DOMS during the week leading up to the test session - Former surgery in neck or shoulder - Pregnancy - Drug addiction defined as the use of cannabis, opioids or other drugs - Previous neurologic, musculoskeletal (other than neck pain) or mental illnesses that could affect the results - Abnormally disrupted sleep in the 24 hours preceding the experiment - Lack of ability to cooperate |
Country | Name | City | State |
---|---|---|---|
Denmark | FysioDanmark Aalborg | Aalborg | |
Denmark | Dept. Of Health Science and Technology, Aalborg University | Gistrup |
Lead Sponsor | Collaborator |
---|---|
Aalborg University |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Neck Disability Index (NDI) | The NDI questionnaire consists of 10 items (Domains: pain intensity, personal care, lifting, reading, headache, concentration, work, driving, sleeping, recreation) used to assess how neck pain affects your ability to manage everyday activities. Each item is score on a scale from 0-5 with a higher total score = high level of disability | At the beginning of the single test session (approximately 45minutes) at day 1 | |
Other | Tampa Scale for Kinesiophobia (TSK-11) | The TSK-11 questionnaire consists of 11 items which is answered using a 4-point scale (1 = strongly disagree, 2 = disagree, 3 = agree, 4 = strongly agree). Score can range from 11 to 44 and a higher score indicated a greater kinesiophobia | At the beginning of the single test session (approximately 45minutes) at day 1 | |
Other | Perceived area of neck pain | Participants will draw the area of perceived neck pain on a body chart | At the beginning of the single test session (approximately 45minutes) at day 1 | |
Other | Fear Avoidance Beliefs Questionnaire-physical activity subscale (FABQpa) | The FABQpa subscale consists of 4 items which are used to assess the participants beliefs on how physical activity can affect their pain. The items are scored on a 7-point scale with 0 = Completely disagree and 6 = Completely agree. Score ranges from 0-24 with a higher score indicating higher fear avoidance beliefs with regards to physical activity | Time Frame: At the beginning of the single test session (approximately 45minutes) at day 1 | |
Primary | Range of motion | Range of motion will be assessed during head rotations (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position) | During a single test session (approximately 45minutes) at day 1 | |
Secondary | Head repositioning accuracy | Head repositioning accuracy will be assessed as the error between the starting point and the end point following a head rotation (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position) and will be repressed in degrees. | During a single test session (approximately 45minutes) at day 1 | |
Secondary | Quality of head movement | Quality of movement (smoothness) will be determined using calculations of jerk variance (Jerk is the time derivative of acceleration which will be measures using an inertial measurement unit. The measure will be converted to a unitless measure where higher values indicates less smooth movements), assessed during head rotations (i.e. moving the head from a neutral position to end of range in rotation before returning to the start position). | During a single test session (approximately 45minutes) at day 1 | |
Secondary | Perceived stiffness during movement | Participants will rate their perceived stiffness during head movement using a 0-100 numerical rating scale, where 0 = no stiffness and 100 = worst stiffness imaginable. | During a single test session (approximately 45minutes) at day 1 | |
Secondary | Perceived difficultness of performing movement | Participants will rate the Perceived difficultness of performing head movements using a 6-point Likert scale going from 0 = no problems, 1 = minimally difficult; 2 = somewhat difficult; 3 = fairly difficult; 4 = very difficult; 5 = unable to perform | During a single test session (approximately 45minutes) at day 1 | |
Secondary | Perceived neck pain intensity | Participants will rate ant potential pain during the session using a 0-11 numeric rating scale (NRS) with 0 = no pain and 10 = worst imaginable pain | During a single test session (approximately 45minutes) at day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |